Tine Thurison Soerensen, PhD

TitlePostdoctoral Scholar
SchoolUCSF School of Pharmacy
DepartmentPharmaceutical Chemistry
Address600 16th Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California San FranciscoPost doc2015Pharm Chem, Craik Lab
    University of CopenhagenPost doc2015The Finsen Laboratory/BRIC, Ploug Lab
    University of CopenhagenPh.D2014Faculty of Health Sciences
    Copenhagen University HospitalResearch assistant2010The Finsen Laboratory, Hoyer-Hansen Lab
    University of CopenhagenM.Sc.2009Faculty of Health Sciences
    Collapse Awards and Honors
    The Danish Cancer Society2012  - 2014Independent Junior Research Grant

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Thurison T, Almholt K, Gårdsvoll H, Ploug M, Høyer-Hansen G, Lund IK. Urokinase receptor cleavage correlates with tumor volume in a transgenic mouse model of breast cancer. Mol Carcinog. 2016 May; 55(5):717-31. PMID: 25809119.
      View in: PubMed
    2. Thurison T, Christensen IJ, Lund IK, Nielsen HJ, Høyer-Hansen G. Circulating intact and cleaved forms of the urokinase-type plasminogen activator receptor: biological variation, reference intervals and clinical useful cut-points. Clin Chim Acta. 2015 Jan 15; 439:84-90. PMID: 25305537.
      View in: PubMed
    3. Illemann M, Laerum OD, Hasselby JP, Thurison T, Høyer-Hansen G, Nielsen HJ, Christensen IJ. Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer. Cancer Med. 2014 Aug; 3(4):855-64. PMID: 24889870; PMCID: PMC4303153.
    4. Grunnet M, Christensen IJ, Lassen U, Jensen LH, Lydolph M, Lund IK, Thurison T, Høyer-Hansen G, Mau-Sørensen M. Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. Clin Biochem. 2014 May; 47(7-8):599-604. PMID: 24530340.
      View in: PubMed
    5. Lund IK, Illemann M, Thurison T, Christensen IJ, Høyer-Hansen G. uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy. Curr Drug Targets. 2011 Nov; 12(12):1744-60. PMID: 21707477.
      View in: PubMed
    6. Thurison T, Lomholt AF, Rasch MG, Lund IK, Nielsen HJ, Christensen IJ, Høyer-Hansen G. A new assay for measurement of the liberated domain I of the urokinase receptor in plasma improves the prediction of survival in colorectal cancer. Clin Chem. 2010 Oct; 56(10):1636-40. PMID: 20802096.
      View in: PubMed
    7. Olson FJ, Thurison T, Ryndel M, Høyer-Hansen G, Fagerberg B. Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability. Clin Biochem. 2010 Jan; 43(1-2):124-30. PMID: 19822140.
      View in: PubMed
    Tine Thurison's Networks
    Derived automatically from this person's publications.
    Related Authors
    People who share related concepts with this person.
    Back to TOP